High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007-2011: Concordant predictions between MATS and genetic MATS.
4CMenB
Australia
MATS
Meningococcal serogroup B
gMATS
strain coverage
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
02 09 2021
02 09 2021
Historique:
pubmed:
14
4
2021
medline:
26
10
2021
entrez:
13
4
2021
Statut:
ppublish
Résumé
Meningococcal serogroup B (MenB) accounts for an important proportion of invasive meningococcal disease (IMD). The 4-component vaccine against MenB (4CMenB) is composed of factor H binding protein (fHbp), neisserial heparin-binding antigen (NHBA),
Identifiants
pubmed: 33847225
doi: 10.1080/21645515.2021.1904758
pmc: PMC8381844
doi:
Substances chimiques
Antigens, Bacterial
0
Meningococcal Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3230-3238Références
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4494-9
pubmed: 21368196
Vaccine. 2016 Jan 20;34(4):510-515
pubmed: 26686998
mSphere. 2017 Nov 15;2(6):
pubmed: 29152576
PLoS One. 2017 May 1;12(5):e0176177
pubmed: 28459837
Vaccine. 2015 May 28;33(23):2629-36
pubmed: 25882169
Int J Med Microbiol. 2018 Mar;308(2):256-262
pubmed: 29153620
Epidemiol Infect. 2016 Aug;144(11):2382-91
pubmed: 27094814
PLoS One. 2016 Mar 07;11(3):e0150721
pubmed: 26950303
Rev Chilena Infectol. 2014 Aug;31(4):377-84
pubmed: 25327189
Vaccine. 2019 Feb 8;37(7):991-1000
pubmed: 30661831
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5
pubmed: 9501229
Vaccine. 2013 Oct 9;31(43):4968-74
pubmed: 23954380
Vaccine. 2013 Dec 17;32(1):124-30
pubmed: 23588089
Hum Vaccin Immunother. 2020 Apr 2;16(4):945-948
pubmed: 31770063
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19490-5
pubmed: 20962280
BMC Genomics. 2016 Oct 28;17(1):843
pubmed: 27793092
Commun Dis Intell (2018). 2020 Mar 16;44:
pubmed: 32178605
Clin Vaccine Immunol. 2010 Jun;17(6):919-29
pubmed: 20375242
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33055180
BMC Microbiol. 2014 Apr 29;14:111
pubmed: 24779381
Clin Vaccine Immunol. 2012 Oct;19(10):1609-17
pubmed: 22875603
Vaccines (Basel). 2020 Aug 22;8(3):
pubmed: 32842669
Lancet Infect Dis. 2017 Jul;17(7):754-762
pubmed: 28366725
Med J Aust. 2017 Nov 6;207(9):382-387
pubmed: 29092704
mSphere. 2018 Aug 22;3(4):
pubmed: 30135218
Lancet Infect Dis. 2013 May;13(5):416-25
pubmed: 23414709
Comput Struct Biotechnol J. 2018 Feb 15;16:61-69
pubmed: 29686800
N Engl J Med. 2020 Jan 23;382(4):309-317
pubmed: 31971676
Vaccine. 2016 May 17;34(23):2579-84
pubmed: 27083425
Methods Mol Biol. 2019;1969:205-215
pubmed: 30877679
Expert Rev Vaccines. 2019 Jan;18(1):15-30
pubmed: 30526162
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10834-9
pubmed: 16825336
PLoS One. 2017 Oct 24;12(10):e0186839
pubmed: 29065137